Oragenics, Inc. (OGEN) Insider Trading Activity

AMEX$0.6389+0.01 (1.59%)
Market Cap
$2.62M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
722 of 885
Rank in Industry
416 of 507

OGEN Insider Trading Activity

OGEN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$74,206
5
100

Related Transactions

Telling Freddirector
0
$0
1
$198
$-198
Odyssey Health, Inc.10 percent owner
0
$0
4
$74,007
$-74,007

About Oragenics, Inc.

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Insider Activity of Oragenics, Inc.

Over the last 12 months, insiders at Oragenics, Inc. have bought $0 and sold $74,206 worth of Oragenics, Inc. stock.

On average, over the past 5 years, insiders at Oragenics, Inc. have bought $303,677 and sold $53,782 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,084 shares for transaction amount of $2,884 was made by Telling Fred () on 2022‑06‑17.

List of Insider Buy and Sell Transactions, Oragenics, Inc.

2025-12-12SaleTelling Freddirector
210
0.0052%
$0.94
$198
-9.25%
2025-06-18SaleOdyssey Health, Inc.10 percent owner
5,044
0.8091%
$4.26
$21,487
-69.27%
2025-06-17SaleOdyssey Health, Inc.10 percent owner
2,000
0.2851%
$4.46
$8,920
-73.91%
2025-06-16SaleOdyssey Health, Inc.10 percent owner
5,000
0.7145%
$4.45
$22,250
-73.79%
2025-06-13SaleOdyssey Health, Inc.10 percent owner
5,000
0.6841%
$4.27
$21,350
-73.85%
2024-12-06SaleTelling Freddirector
3,597
0.0303%
$0.36
$1,295
-61.41%
2024-12-06SaleDUNTON ALAN Wdirector
66
0.0006%
$0.36
$24
-61.41%
2023-11-30SaleTelling Freddirector
3,500
0.3216%
$3.57
$12,488
-65.64%
2022-12-30SaleKOSKI ROBERT Cdirector
42,357
0.1151%
$0.11
$4,469
-45.61%
2022-12-29SaleKOSKI ROBERT Cdirector
36,648
0.1%
$0.11
$3,885
-48.03%
2022-12-15SaleKOSKI ROBERT Cdirector
140,497
0.636%
$0.18
$24,699
-66.33%
2022-12-14SaleKOSKI ROBERT Cdirector
29,503
0.1329%
$0.17
$5,163
-66.37%
2022-12-09SaleKOSKI ROBERT Cdirector
48,795
0.2475%
$0.20
$9,613
-69.51%
2022-12-08SaleKOSKI ROBERT Cdirector
13,036
0.0671%
$0.20
$2,607
-69.91%
2022-11-30SaleKOSKI ROBERT Cdirector
200,000
0.9841%
$0.19
$38,220
-70.87%
2022-11-29SaleKOSKI ROBERT Cdirector
200,000
0.9903%
$0.19
$38,460
-69.83%
2022-06-17PurchaseTelling Fred
10,084
0.0743%
$0.29
$2,884
-47.09%
2022-05-23PurchaseTelling Freddirector
82,173
0.6123%
$0.29
$23,780
-31.79%
2022-05-20PurchaseTelling Fred
65,718
0.4799%
$0.28
$18,638
-29.48%
2022-05-19PurchaseTelling Freddirector
56,806
0.4106%
$0.28
$15,945
-29.29%
Total: 142
*Gray background shows transactions not older than one year

Insider Historical Profitability

79.42%
Telling Freddirector
948
0.0227%
$596.86153
+79.42%
Odyssey Health, Inc.10 percent owner
0
0%
$004
KIRK RANDAL J10 percent owner
14481089
347.4164%
$9.12M30
HAWES GEORGE T10 percent owner
10857235
260.4764%
$6.84M519
HILLMAN JEFFREY DDirector
4202394
100.8198%
$2.65M12
KOSKI ROBERT Cdirector
1102295
26.4452%
$694,004.93211
ZAHRADNIK ROBERT T
881000
21.1361%
$554,677.6010
SOPONIS MENTO
520133
12.4785%
$327,475.7402
BONFIGLIO JOHN NPresident and CEO
385255
9.2427%
$242,556.5520
KOSKI FAMILY LP10 percent owner
277839
6.6656%
$174,927.43267
GURY DAVID Jdirector
125000
2.9989%
$78,700.0020
Evens Ronald Pdirector
113636
2.7262%
$71,545.2310
POPE CHARLES Ldirector
111063
2.6645%
$69,925.2601
Joslyn AlanSee Remarks
66667
1.5994%
$41,973.5410
Sullivan Michael O'KeefeInterim PEO, CFO
34255
0.8218%
$21,566.9510
DUNTON ALAN Wdirector
25623
0.6147%
$16,132.24116
Bohunicky Brian JohnCFO, Secretary and Treasurer
25000
0.5998%
$15,740.0010
ANDERSON BRIANdirector
0
0%
$011
Hernandez Joseph10 percent owner
0
0%
$009
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,848,072
66
-14.67%
$2.37M
$1,138,733
28
-4.94%
$3.39M
$29,635,355
27
9.05%
$4.2M
$337,688
19
-33.30%
$3.88M
$82,890
11
-16.74%
$1.6M
$105,917
11
-28.06%
$2.28M
$126,023
10
-66.17%
$2.59M
$18,269
10
-21.15%
$2.41M
$90,087
9
20.06%
$2.17M
$8,971,546
8
6.18%
$4.14M
$7,268,979
7
-48.44%
$2.59M
$192,099
7
-39.17%
$4.94M
$245,000
7
-62.00%
$3.12M
$70,828
6
-57.96%
$1.54M
$149,778
4
-45.16%
$3.17M
$76,299
4
11.60%
$4.86M
$4,423
2
3.27%
$4.72M
$9,963
1
-14.25%
$2.4M
Oragenics, Inc.
(OGEN)
$37,000
1
79.42%
$2.62M

OGEN Institutional Investors: Active Positions

Increased Positions7+41.18%182,600+229.54%
Decreased Positions4-23.53%16,302-20.49%
New Positions5New129,577New
Sold Out Positions2Sold Out335Sold Out
Total Postitions20+17.65%245,847+209.05%

OGEN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Clear Street Llc$59.001.77%70,619+70,619New2025-06-30
Drw Securities, Llc$52.001.55%61,809+61,809New2025-09-30
Sabby Management, Llc$49.001.47%58,953+58,953New2025-09-30
Blackrock, Inc.$1.000.02%703+2+0.28%2025-09-30
Allworth Financial Lp$00.01%334+334New2025-09-30
Ubs Group Ag$00.01%271-1,621-85.68%2025-09-30
Tower Research Capital Llc (Trc)$00.01%208-457-68.72%2025-09-30
Morgan Stanley$0<0.01%138-11,774-98.84%2025-09-30
Bank Of America Corp /De/$0<0.01%36-15,510-99.77%2025-09-30
Harbour Investments, Inc.$0<0.01%3400%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.